SSTR2 and pituitary gland adenoma: It has been suggested that low levels of filamin A, a cytoskeletal-associated protein, could represent a post-receptor mechanism of pharmacological resistance in pituitary adenomas, as this scaffolding protein stabilizes the SSTR2 and dopamine 2 receptor, linking them to their intracellular effectors [69, 70].